• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        Clot Retraction Test

        互联网

        1374

         

        OUTLINE

        Abnormal Clot Retraction indicates on abnormal platelet numbers, abnormal glycoprotein amount or structure, abnormal platelet signaling, abnormal fibrinogen levels, or abnormal fibrinogen structure

        PROTOCOL
         
        1. Use either the whole blood or platelet-rich plasma (PRP)
        2. To obtain PRP, collect 500 µl of blood on 50 µl of ACD
        3. Add 600 µl of PBS, centrifuge once at 10ѓC, 1200 rpm ( Joan, GR 412)
        4. In Glass Centrifuge Tube add 100 µl of PRP and 160µl of clot retraction buffer, and 50µl of  working solution of thrombin (8 U/mL) and 5-10 µL of erythrocytes (for visualization). Vortex briefly.
        5. Place the Dead End Glass Rod (use Pasteur Pipette)  to the bottom of the tube. Place the tube at 37ѓC. Check the CLOT FORMATION (appearance) and RETRACTION. Measure the volume of remained solution after clot retraction, notice the color of solution, take digital picture.

        SOLUTIONS
         
        1. Clot Retraction Buffer: 400 mL of PBS x1 + 10 mL of PBS-MgCl2 (MgCm2=4g/L) + 10 mL PBS-CaCl2 (CaCl2= 5.3 g/L)
        2. Working Solution of Thrombin = 7 µl of Thrombin (1250U/mL) + 1 mL of Clot Retraction Buffer

        ADDITIONAL INFO

        The Clot Retraction Test may be used for screening of new anti-platelet drugs, anti-platelet-antibodies, or unexplained bleeding-problems. This test does not indicate exactly what is the problem but shows the direction to look for it.


        REFERENCES
         
        1. Platelet Protocols. Research and Clinical Laboratory Procedures. McCabe White M. and Jennings L.K. Academic Press, 1999
        2. Azam M. et al, Molecular Cellular Biology, March 2001, p. 2213-2230, Vol. 21, No. 6
        3. Hodivala-Dilke KM et al, Beta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival. J. Clin. Investig. 103:229-238

         

        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序